Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13164* | 2021 |
Validity and reliability of a rating scale for the primary torsion dystonias RE Burke, S Fahn, CD Marsden, SB Bressman, C Moskowitz, J Friedman Neurology 35 (1), 73-73, 1985 | 1188 | 1985 |
Clinical progression in Parkinson disease and the neurobiology of axons HC Cheng, CM Ulane, RE Burke Annals of neurology 67 (6), 715-725, 2010 | 1108 | 2010 |
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP W Dauer, N Kholodilov, M Vila, AC Trillat, R Goodchild, KE Larsen, ... Proceedings of the National Academy of Sciences 99 (22), 14524, 2002 | 722 | 2002 |
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine V Jackson-Lewis, M Jakowec, RE Burke, S Przedborski Neurodegeneration 4 (3), 257-269, 1995 | 697 | 1995 |
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease Y Li, W Liu, TF Oo, L Wang, Y Tang, V Jackson-Lewis, C Zhou, ... Nature neuroscience 12 (7), 826-828, 2009 | 605 | 2009 |
Tardive dystonia RE Burke, S Fahn, J Jankovic, CD Marsden, AE Lang, S Gollomp, J Ilson Neurology 32 (12), 1335-1335, 1982 | 603 | 1982 |
Axon degeneration in Parkinson's disease RE Burke, K O'Malley Experimental neurology 246, 72-83, 2013 | 505 | 2013 |
Pitx3 is required for development of substantia nigra dopaminergic neurons I Nunes, LT Tovmasian, RM Silva, RE Burke, SP Goff Proceedings of the National Academy of Sciences 100 (7), 4245, 2003 | 457 | 2003 |
A critical evaluation of the Braak staging scheme for Parkinson's disease RE Burke, WT Dauer, JPG Vonsattel Annals of Neurology: Official Journal of the American Neurological …, 2008 | 439 | 2008 |
6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death BS Jeon, V Jackson-Lewis, RE Burke Neurodegeneration 4 (2), 131-137, 1995 | 413 | 1995 |
Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. WT Dauer, RE Burke, P Greene, S Fahn Brain 121 (4), 547, 1998 | 378 | 1998 |
Regulation of Presynaptic Neurotransmission by Macroautophagy D Hernandez, CA Torres, W Setlik, C Cebrián, EV Mosharov, G Tang, ... Neuron 74 (2), 277-284, 2012 | 359 | 2012 |
CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism RM Silva, V Ries, TF Oo, O Yarygina, V Jackson‐Lewis, EJ Ryu, PD Lu, ... Journal of neurochemistry 95 (4), 974-986, 2005 | 331 | 2005 |
Human gene for torsion dystonia located on chromosome 9q32-q34 L Ozelius, PL Kramer, CB Moskowitz, DJ Kwiatkowski, MF Brin, ... Neuron 2 (5), 1427-1434, 1989 | 327 | 1989 |
Torsion dystonia RE Burke, S Fahn, CD Marsden Neurology 36 (2), 160-160, 1986 | 324 | 1986 |
Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance SB Bressman, D De Leon, MF Brin, N Risch, RE Burke, PE Greene, ... Annals of Neurology: Official Journal of the American Neurological …, 1989 | 272 | 1989 |
Retrograde axonal degeneration in Parkinson disease P Tagliaferro, RE Burke Journal of Parkinson's disease 6 (1), 1-15, 2016 | 256 | 2016 |
Delayed-onset dystonia in patients with" static" encephalopathy. RE Burke, S Fahn, AP Gold Journal of Neurology, Neurosurgery & Psychiatry 43 (9), 789, 1980 | 253 | 1980 |
Apoptosis in neurodegenerative disorders. L Stefanis, RE Burke, LA Greene Current opinion in neurology 10 (4), 299, 1997 | 233 | 1997 |